To further confirm the roles of ERK1/2 downstream of AGO1 in SKOV3 cells, ERK inhibitor LY3214996 or P38 inhibitor SB203580 was treated to investigate the changes of ovarian cancer cell functions. Here, MAPK3 is linked to ovarian cancer.